SLN Mapping and ICG Dye for Vulvar Cancer
Key facts
- Who runs it
- Tufts Medical Center
- Where
- Boston, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 10 people, planned
- Started
- 1 Nov 2025
- Planned end
- Jan 2026
- Type of study
- Observational
- Treatments tested
- Indocyanine green
- Record updated
- 29 September 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- 18 years of age or older
- Patients with early-stage SCC (diameter <4 cm) of the vulva without suspicious lymph nodes at palpation or imaging who are planned for surgery at Tufts Medical Center
- Patients with squamous cell carcinoma, depth of invasion > 1mm
- Patients with T1 or T2 tumors (FIGO staging) < 4 cm, not encroaching in urethra or anus with clinically negative inguinofemoral lymph nodes
- Localization and size of the tumor are such that perilesional injection of the tracers at three or four sites is possible
- Preoperative imaging do not show enlarged (<1.5 cm)/ suspicious nodes
- Willing and able to give informed consent
Who cannot take part
- Inoperable tumors and tumors with diameter > 4 cm
- Patients with inguinofemoral lymph nodes that are palpable on clinical exam suspicious for metastases or with cytologically proven inguinofemoral lymph node metastases
- Radiologically enlarged (>1.5 cm) inguinofemoral lymph nodes
- Patients with multifocal tumors
- Pregnancy
Where in United States
- Tufts Medical CenterBoston, United StatesContact: Alysa St. Charles, MANot yet recruiting
About the trial
What the trial wants to find out
Doctors typically use blue dye to assist in locating and extracting lymph nodes for biopsy. However, this process can prove somewhat challenging for both patients and medical teams due to its need for extensive coordination and the assistance of a nuclear medicine team. Some studies have talked about using a different method to find these lymph nodes using a special dye called Indocyanine Green (ICG). This method involves shining a special camera on the skin. So far, no studies have directly compared the ICG method to the standard blue dye. The ICG camera could make things easier for patients and doctors, and more patients might choose to have their lymph nodes checked with this new method. The goal of our study is to see if using the ICG dye is just as good as the standard method of blue dye.
The group in the trial
- Combined ICG dye and blue tracer dye
This study is being done to see if a different way of finding and removing lymph nodes during surgery, using a special camera and a dye called Indocyanine Green (ICG), works as well as the usual method with blue dye plus a radioactive tracer called radiocolloid. By comparing the two ways directly, we hope to make it simpler for people with vulvar cancer to get their lymph nodes checked during surgery.
Treatment: Indocyanine green
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Sentinel Lymph Node Mapping and Detection With Indocyanine Green and Spy-Phi Handheld Camera Technology in Early-Stage Vulvar Cancer (PILOT)
- Record updated
- 29 September 2025